Loyal / Cellular Longevity
www.loyalfordogs.comLoyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.
Read moreLoyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.
Read moreCountry
State
California
City (Headquarters)
San Francisco
Industry
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President , Regulatory and Strategy
Email ****** @****.comPhone (***) ****-****Chief Creative Officer
Email ****** @****.comPhone (***) ****-****Founder and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Director of Engineering
Email ****** @****.comPhone (***) ****-****
Technologies
(61)